Go Back

Aynur Özge

Aynur Özge

Institution: Mersin University School of Medicine
City: Mersin
Country: Turkey

Biography

Professor Aynur Özge is Professor of Neurology, Algology and Clinical Neurophysiology at Mersin University School of Medicine Department of Neurology in Turkey, an international lecturer, writer, and president of Global Migraine and Pain Summit together with MENA Organisation.

 She is Co-Editor of three international books, two of them about childhood headaches, the other about peripheral interventions in headache medicine.

She has been an active member of IHS since 2004, and has actively served in the Child and Adolescent and Classification committees. She was elected to serve as a Co-opted Board member of the Society for the 2019–2021 term.

Professor Özge has served as the Organising Committee Chair of the 7th International Child-Adolescent Headache Congress held in Istanbul in 2008. She is the Organising Committee Chair of the 4th MENA and 2nd Turkish-African Migraine-Pain Congress, which was held in Antalya in 2020. She is the President of the Global Migraine Pain Summit, established in 2019 to raise social awareness about migraine and painful syndromes.

 Professor Özge's H index score, is 26. She is the author of two public information books which are on sale to benefit various NGOs.

Disclosures

Employment: Mersin University Department of Neurology

Society Leadership/Board position: Chair Global Migraine and Pain Society; Chair Mersin Alzheimer Society

Personal fees: Lilly; TEVA; Pfizer; Abbvie (Allergan); Novartis; Abdi İbrahim; Ali Raif İlaç; İlko İlaç; Neutec ilaç

Research support: Abdi İbrahim; Abbvie; Lilly

Royalties/Licences: Springer book royalties

Clinical trials involvement: Subinvestigator Noema Pharma NOE-TGN-201, Allergan CAPTURE study

Relationship with scientific journals: Cephalalgia, Headache, Journal of Headache and Pain, Neurology, Pediatrics, Neurological Sciences and Neurophysiology, Arch Neuropsychiatry, Frontiers in Neurology, BMC Neurology, Lancet Neurology

Commercial interests: None